Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
The Journal of Infectious Diseases
|
November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Scientific Reports
|
February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
Guillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Science Translational Medicine
|
December 13, 2019
A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus
Jody Hobson-Peters, Jessica J Harrison, Daniel Watterson, et al.
Nature Aging
|
November 13, 2023
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology
Julio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.
Nature Structural & Molecular Biology
|
July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escape
Ariel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
The Lancet. Infectious Diseases
|
April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Molecular Psychiatry
|
November 1, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A Albornoz, Alberto A Amarilla, Naphak Modhiran, et al.
Vaccines
|
July 27, 2024
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster
Tatiana A do Nascimento, Patricia Y Nogami, Camille F de Oliveira, et al.
Iscience
|
June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
Naphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Nature Communications
|
June 9, 2021
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
Alberto A Amarilla, Julian D J Sng, Rhys Parry, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
The Journal of Infectious Diseases
|
November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Scientific Reports
|
February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody
Guillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Science Translational Medicine
|
December 13, 2019
A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus
Jody Hobson-Peters, Jessica J Harrison, Daniel Watterson, et al.
Nature Aging
|
November 13, 2023
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology
Julio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.
Nature Structural & Molecular Biology
|
July 8, 2025
A nanobody-based therapeutic targeting Nipah virus limits viral escape
Ariel Isaacs, Guillermo Valenzuela Nieto, Xinghai Zhang, et al.
The Lancet. Infectious Diseases
|
April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Molecular Psychiatry
|
November 1, 2022
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A Albornoz, Alberto A Amarilla, Naphak Modhiran, et al.
Vaccines
|
July 27, 2024
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster
Tatiana A do Nascimento, Patricia Y Nogami, Camille F de Oliveira, et al.
Iscience
|
June 26, 2023
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
Naphak Modhiran, Simon Malte Lauer, Alberto A Amarilla, et al.
Nature Communications
|
June 9, 2021
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
Alberto A Amarilla, Julian D J Sng, Rhys Parry, et al.
Page
of 8